Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBringing up yellow or green bile while taking Wegovy is unsettling, but it does have a clear explanation. Wegovy (semaglutide) slows gastric emptying significantly, and when your stomach is already empty, retching or vomiting produces bile rather than food. It is one of the more distressing forms of nausea that patients report, particularly in the days after starting treatment or moving to a higher dose. This is a prescription-only medicine; a prescriber who knows your full picture is best placed to advise whether any change is needed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing the rate at which the stomach empties its contents into the small intestine. That mechanism is intentional (it helps you feel full for longer) but it also means that if nausea arrives when there is little or no food left in your stomach, there is nothing to bring up except bile, the greenish-yellow digestive fluid produced by the liver. The result is that characteristic bitter, burning sensation in the throat that patients describe as worse than ordinary vomiting.
The Wegovy treatment overview sets out how semaglutide's GLP-1 receptor activity affects both appetite signalling in the brain and gut motility. Both pathways contribute here: the brain is receiving signals to reduce intake while the gut is moving more slowly than usual, so the combination can tip into nausea that empties an already-quiet stomach entirely. A question our prescribers hear most weeks is whether Wegovy made them throw up in a way that means the medicine is not right for them — the honest answer is that for most people it is temporary, not a sign that treatment should stop.
The NHS semaglutide medicines page lists nausea and vomiting among the most common side effects, and notes that they are generally most noticeable when treatment starts or the dose increases, easing as the body adapts. Bile vomiting sits within that category, a more intense presentation of the same underlying mechanism.
Timing is often the key factor. Bile vomiting on Wegovy is far more likely when nausea arrives on an empty stomach, most commonly in the morning, or several hours after a meal. Eating very little but eating regularly can make a meaningful difference. Small, bland portions (plain crackers, toast, plain rice) every few hours give the stomach something to work with, rather than leaving it to contract on nothing.
A few other patterns tend to make it worse. Eating a large, fatty or very rich meal and then lying down compounds the slowed-emptying effect; fizzy drinks can add to the sensation of bloating and reflux that precedes vomiting. Cold or room-temperature fluids in small sips are usually better tolerated than hot drinks immediately after eating. The guide to vomiting on Wegovy covers practical management in more detail, but the core principle is the same: reduce the load on a stomach that is already working slowly.
For some people, throwing up after the semaglutide shot is worst on injection day and the day after. If that pattern is consistent, it is worth mentioning to your prescriber, the timing of the weekly injection relative to your usual meal schedule can sometimes be adjusted. Dose titration exists precisely to allow the body time to adapt; if bile vomiting is severe and persistent, staying at the current dose for longer before any increase is a legitimate clinical decision, not a failure.
Occasional bile vomiting that settles within a day or two after a dose change is within the expected range of GLP-1 side effects. The situations that need prompt medical attention are different in character. If vomiting is so frequent that you cannot keep fluids down for more than twelve to twenty-four hours, dehydration becomes a real risk, and that can affect kidney function, especially relevant at higher Wegovy doses.
Severe, persistent abdominal pain that spreads toward the back, with or without vomiting, should be assessed urgently. The MHRA highlighted acute pancreatitis as a known, though infrequent, serious side effect of GLP-1 medicines in a Drug Safety Update issued in January 2026; that is one of the key symptoms to be aware of. Pancreatitis is uncommon, but it requires immediate assessment rather than waiting to see whether things improve.
Signs of a more severe allergic reaction (swelling of the face, lips or throat, or difficulty breathing) are also reasons to call 999 rather than manage at home. For anything that feels uncertain rather than acute, the nume support team is available seven days a week and can help you judge whether a prescriber needs to review your situation. You can also report unexpected side effects directly to the MHRA via Yellow Card.
For the majority of people, it does not. Bile vomiting is distressing, but it is not automatically a signal that semaglutide is unsuitable. The clinical question is whether the side effect is improving with time and manageable with practical steps, or whether it is persistent, severe, and affecting your ability to stay hydrated and nourished.
Stopping treatment abruptly is a decision best made with your prescriber rather than alone. Weight that was lost tends to return without ongoing treatment, and the prescriber may have options (holding the current dose for longer, reviewing your injection timing, or suggesting anti-nausea strategies) before concluding that the medicine is not the right fit. The semaglutide information page gives broader context on how long side effects typically last and what the titration schedule is designed to achieve.
If you are weighing up how the injectable and tablet forms compare, or looking at what Wegovy treatment costs as part of a wider decision, those are also worth discussing at consultation rather than deciding purely on the basis of a difficult first few weeks. People who push through the early adjustment period with proper support often find the GI side effects settle considerably by weeks four to eight.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.